As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…
HOME > ACADEMIA
ACADEMIA
- Anti-TNF-α Antibody Treatment for Crohn’s Disease Costs 1.95 Million Yen per Patient Annually: Study
June 27, 2018
- Licensee Selection Draws Near for AMED-Backed Cancer Mouth Sores Treatment
June 26, 2018
- Nucala, Fasenra to Be Ranked as Strongest Treatments in New Asthma Guidelines: Allergology Society
June 21, 2018
- MHLW Study Group to Discuss Roles of JAK Inhibitors and Biosimilars toward RA Treatment Guidelines Revision
June 5, 2018
- Nephrology Society to Issue New CKD Guidelines; Recommends Less-Strict Blood Pressure Management Target
June 4, 2018
- AZ’s Durvalumab to Become New Treatment Option for Stage III NSCL Cancer: Oncologist
May 28, 2018
- Breast Cancer Society Initiates Trial to Evaluate Efficacy of Denosumab at Increasing Bone Mass
May 21, 2018
- Dupixent Used Generally as Adjunctive Therapy to Existing Treatments for Atopic Dermatitis: Dermatologist
May 10, 2018
- 55 Anticancer Meds Available Overseas Unapproved in Japan, 3 Meds Costing over 10 Million Yen Monthly: NCC
May 2, 2018
- New Guidelines Recommend LAMA as First-Line Bronchodilator for COPD: Respiratory Society
April 24, 2018
- Clinical Trials for Mitochondrial Disease Heating Up with AMED’s Support; Filing for First Hyperlactacidemia Drug Expected in 2020
April 23, 2018
- Expert Cautions against Hasty Discussions on Cost Effective Assessments
April 20, 2018
- Biosimilar Use Essential to Sustain Universal Health Coverage: Society President
April 19, 2018
- Physicians Association Initiates Large-Scale Study to Directly Compare DPP-4 Inhibitors to SGLT2 Inhibitors, Determine “Optimal Patients” for Each
April 19, 2018
- Lynparza Desirable for Use in Early-Stage Maintenance Therapy: Jikei Univ. Prof.
April 2, 2018
- Atherosclerosis Society Issues Statement on Use of PCSK9 Inhibitors, Recommending for Patients with FH, Secondary Prevention in High-Risk Patients
March 6, 2018
- Nephrology Society Compiles New Drug Development Guidelines for Advanced CKD; Will Guidelines for Early-Stage CKD Follow?
March 1, 2018
- LSI Medience, NCC, and NIBIOHN Team Up for National Project to Develop PDX Mice
February 26, 2018
- Major Drug Makers to Join in AMED Project to Develop “Organs on Chips” as New Tools for Drug Discovery
February 22, 2018
- Overseas Meta-Analyses Find Increased Risk of CKD in Patients Who Use PPIs; Japanese Society of Nephrology Plans Study of Japanese Patients
February 2, 2018
ページ
Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…
To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…
While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…